Related Experiment Videos
Periodinates: a new class of protein tyrosine phosphatase inhibitors
K W Leung1, B I Posner, G Just
1Department of Chemistry, McGill University, Montreal, Canada.
Bioorganic & Medicinal Chemistry Letters
|March 26, 1999
Abstract:
A series of periodinates has been synthesized and tested as protein tyrosine phosphatase substrates. Their potency is comparable to or higher than that of vanadates but much lower than that of peroxovanadates.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Muscarinic Acetylcholine Receptor in Dermal Papilla Cells Regulates Hair Growth.
International journal of molecular sciences·2026
Does conventional early life academic excellence predict later life scientific discovery? An assessment of the lives of great medical innovators.
QJM : monthly journal of the Association of Physicians·2020
Antenatal dexamethasone treatment transiently alters diastolic function in the mouse fetal heart.
The Journal of endocrinology·2019
Angiographic factors associated with haemorrhagic presentation of brain arteriovenous malformation in a Chinese paediatric population.
Hong Kong medical journal = Xianggang yi xue za zhi·2015
Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
Hong Kong medical journal = Xianggang yi xue za zhi·2015
Discovery of potent, selective, and orally bioavailable monocyclic pyridine-based PKMYT1 inhibitors that synergize with CHK1 inhibition in replication-stressed cancer cells.
Bioorganic & medicinal chemistry letters·2026
Quinolin(on)es and pyridin(on)es as promising scaffolds against mycobacterial infections.
Bioorganic & medicinal chemistry letters·2026
Amyloid-β aggregation inhibitory activity and neuroprotective effects of metabolites of Trichoderma pluripenicillatum.
Bioorganic & medicinal chemistry letters·2026
Electrophilic aromatic halogenation of perylenequinones: a strategy to improve photodynamic properties.
Bioorganic & medicinal chemistry letters·2026
Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer.
Bioorganic & medicinal chemistry letters·2026
Model-based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications.
Clinical pharmacology and therapeutics·2026
Targeting Serotonin 5-HT2A Receptors in the Treatment of Aggression: from Antipsychotics to Psychedelics.
Aggression and violent behavior·2026
Where do people obtain side effect information? Results from a census-matched U.S. national survey.
Exploratory research in clinical and social pharmacy·2026